Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1995
Explicit and procedural memory in Parkinson's disease
H Allain, A Lieury, V Thomas, et al.
Revue Neurologique
|
May 30, 2003
[Neuropsychological and scintigraphic aspects of frontotemporal dementia preceding amyotrophic lateral sclerosis]
M Vercelletto, S Belliard, S Wiertlewski, et al.
Dementia (Basel, Switzerland)
|
November 1, 1993
Potential biological targets for anti-Alzheimer drugs
H Allain, S Belliard, J de Certaines, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1994
Monoamine oxidase inhibitors, cognitive functions and neurodegenerative diseases
J C Delumeau, D Bentué-Ferrer, J M Gandon, et al.
Therapie
|
March 1, 1996
[Randomized double-blind comparative study of minaprine (200mg/j) and of placebo on memory loss]
H Allain, S Belliard, A Lieury, et al.
British Journal of Pharmacology
|
March 12, 2013
Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil
M Uguen, D Perrin, S Belliard, et al.
Revue Neurologique
|
December 3, 2014
[Specificities of the logopenic variant of primary progressive aphasia]
E Magnin, M Teichmann, O Martinaud, et al.
Annals of Neurology
|
September 8, 2000
Alpha2-macroglobulin gene and Alzheimer's disease: confirmation of association by haplotypes analyses
P Verpillat, S Bouley, D Hannequin, et al.
European Journal of Human Genetics : EJHG
|
July 4, 2001
Use of haplotype information to test involvement of the LRP gene in Alzheimer's disease in the French population
P Verpillat, S Bouley, D Campion, et al.
European Journal of Human Genetics : EJHG
|
September 12, 2000
APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population
L Zurutuza, P Verpillat, G Raux, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1995
Explicit and procedural memory in Parkinson's disease
H Allain, A Lieury, V Thomas, et al.
Revue Neurologique
|
May 30, 2003
[Neuropsychological and scintigraphic aspects of frontotemporal dementia preceding amyotrophic lateral sclerosis]
M Vercelletto, S Belliard, S Wiertlewski, et al.
Dementia (Basel, Switzerland)
|
November 1, 1993
Potential biological targets for anti-Alzheimer drugs
H Allain, S Belliard, J de Certaines, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1994
Monoamine oxidase inhibitors, cognitive functions and neurodegenerative diseases
J C Delumeau, D Bentué-Ferrer, J M Gandon, et al.
Therapie
|
March 1, 1996
[Randomized double-blind comparative study of minaprine (200mg/j) and of placebo on memory loss]
H Allain, S Belliard, A Lieury, et al.
British Journal of Pharmacology
|
March 12, 2013
Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil
M Uguen, D Perrin, S Belliard, et al.
Revue Neurologique
|
December 3, 2014
[Specificities of the logopenic variant of primary progressive aphasia]
E Magnin, M Teichmann, O Martinaud, et al.
Annals of Neurology
|
September 8, 2000
Alpha2-macroglobulin gene and Alzheimer's disease: confirmation of association by haplotypes analyses
P Verpillat, S Bouley, D Hannequin, et al.
European Journal of Human Genetics : EJHG
|
July 4, 2001
Use of haplotype information to test involvement of the LRP gene in Alzheimer's disease in the French population
P Verpillat, S Bouley, D Campion, et al.
European Journal of Human Genetics : EJHG
|
September 12, 2000
APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population
L Zurutuza, P Verpillat, G Raux, et al.
Page
of 3